Emergent BioSolutions gets more disappointing news — this time, from the clinic
The study, sponsored by the National Institute of Allergy and Infectious Diseases, tested four antibody therapies including one from the local biotech.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news
More News: Allergy | Allergy & Immunology | Biotechnology | Health Management | Infectious Diseases | Pharmaceuticals | Study